Corpus Intelligence IC Memo — MOUNTAIN VALLEY REGIONAL REHABILITAT 2026-04-26 06:39 UTC
IC Memo — MOUNTAIN VALLEY REGIONAL REHABILITAT
Investment Committee Memorandum | AZ | 44 beds | Grade C | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MOUNTAIN VALLEY REGIONAL REHABILITAT

CCN 033036 | YAVAPAI, AZ | 44 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MOUNTAIN VALLEY REGIONAL REHABILITAT is a 44-bed community hospital in YAVAPAI, AZ with $25.6M in net patient revenue and a 13.8% operating margin. The hospital serves a payer mix of 59.4% Medicare, 0.0% Medicaid, and 40.6% commercial.

Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.8% to 21.1% (+736bps).

Net Revenue HCRIS$25.6M
Current EBITDA COMPUTED$3.5M
Operating Margin COMPUTED13.8%
Occupancy HCRIS78.1%
Revenue / Bed COMPUTED$582K
Net-to-Gross HCRIS73.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
52
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 13.8% places it above the state median. Among 52 size-comparable peers (22-88 beds), the median margin is -1.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-88), prioritizing same-state peers. 52 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MOUNTAIN VALLEY REGIONAL REHAB (Target)AZ44$25.6M13.8%
VERDE VALLEY MEDICAL CENTERAZ87$172.5M4.3%
CANYON VISTA MEDICAL CENTERAZ74$132.6M1.9%
ARIZONA GENERAL HOSPITALAZ50$116.2M-6.6%
HONORHEALTH SONORAN CROSSING MAZ70$94.4M-6.6%
THE CORE INSTITUTE SPECIALTY HAZ28$91.2M9.2%
TEMPE ST. LUKES HOSPITALAZ74$75.8M3.6%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$75.2M-2.8%
COBRE VALLEY REG. MEDICAL CENTAZ25$74.9M-10.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$538K+210bp18mo
Cost to Collect4.5%2.5%$513K+200bp12mo
Denial Rate Reduction12.0%6.5%$507K+198bp12mo
A/R Days Reduction5200.0%3800.0%$312K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$538K
Cost to Collect
$513K
Denial Rate Reduction
$507K
A/R Days Reduction
$312K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.9M
Current EBITDA$3.5M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$5.4M
Current Margin13.8%
Pro Forma Margin21.1%
WC Released (1x)$983K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$5.4M$42.2M7.76x50.6%
Base (11x exit)10.0x11.0x$5.4M$48.1M8.86x54.7%
Bull Case9.0x11.0x$4.9M$56.1M11.48x62.9%
Bull (12x exit)9.0x12.0x$4.9M$62.7M12.82x66.6%
Bear Case11.0x10.0x$6.0M$31.0M5.18x39.0%
Bear (11x exit)11.0x11.0x$6.0M$36.0M6.02x43.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 59.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 52 hospitals with 22-88 beds
  • Same-state prioritization (n=53)
  • Comp margins: P25=-10.8% / P50=-1.1% / P75=4.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.